Dr. Lucia De Martino | Neurooncology | Best Researcher Award
Medical Executive at Santobono Pausilipon Nationally Significant Hospital Company, Italy
Dr. Lucia De Martino, born on January 31, 1986, in Naples, Italy 🇮🇹, is a Consultant at the Neuro-Oncology Unit of AORN Santobono-Pausilipon. With a passion for pediatric neuro-oncology, she has made significant contributions to the diagnosis, treatment, and research of childhood brain tumors. Fluent in English, French, and German 🗣️, Dr. De Martino combines international expertise with compassionate clinical care. She has worked in prestigious institutions, including the Fondazione IRCCS Istituto Nazionale dei Tumori (Milan) and Hôpital Béclère (Paris), reflecting her diverse training. Her work emphasizes evidence-based medicine, multidisciplinary collaboration, and cutting-edge therapies for pediatric patients. She serves as a principal and sub-investigator on several national and international clinical trials targeting DIPG, medulloblastoma, and pediatric gliomas. Driven by scientific curiosity and empathy, she continuously engages in academic, clinical, and ethical advancements, contributing actively to pediatric oncology forums and congresses worldwide 🌍.
professional profile
Education 
Dr. Lucia De Martino’s educational journey reflects a deep commitment to pediatrics and oncology. She earned her Medical Degree from Università di Napoli “Federico II” in 2011 🎓. During her medical studies, she participated in the Erasmus program at the Heinrich Heine University of Düsseldorf (Germany), expanding her academic horizons. She received her Paediatrics Specialization from the same university in 2017 and earned her Master’s Degree in Pediatric Intensive Care from Università Cattolica – Ospedale Gemelli di Roma the same year. Dr. De Martino obtained her Medical License in 2012 and has been registered with the Neapolitan Medical Council (NA033767). Her training is marked by international exposure, practical excellence, and a research-oriented mindset. Through continuous learning, participation in clinical workshops, and evidence-based courses, she keeps her knowledge sharp and aligned with the latest developments in pediatric oncology and intensive care 🧠🩺.
work Experience
Dr. Lucia De Martino began her career with clinical internships at the Pediatric Endocrinology Center, University of Naples (2010–2011). She then engaged in clinical and research work at Hôpital Béclère (Paris) in the Neonatal Intensive Care Unit (2016), followed by a temporary post at the Istituto Nazionale dei Tumori in Milan (2022–2023). Since December 2017, she has served as a Consultant in the Neuro-Oncology Unit of AORN Santobono-Pausilipon, Naples. She is deeply involved in both patient care and research, acting as Principal Investigator and Sub-Investigator in numerous clinical trials on DIPG, ependymoma, medulloblastoma, and glioma. Her current projects include biomarker studies, observational CNS tumor trials, and national registries. Dr. De Martino also contributes to international research efforts like SIOP Europe studies and has collaborated with renowned professionals like Dr. Lucia Quaglietta and Dr. Giuseppe Cinalli. Her work bridges advanced research and compassionate pediatric care 👩⚕️🧬.
Research Focus
Dr. Lucia De Martino’s research centers on pediatric neuro-oncology, particularly focusing on central nervous system (CNS) tumors such as DIPG, medulloblastoma, and ependymoma 🧠🧒. Her research interests include studying molecular markers, biomarkers, and precision therapies to improve diagnosis and treatment outcomes in children. She is involved in several cutting-edge clinical trials, including radiotherapy combined with nimotuzumab and vinorelbine, biobank projects, and retrospective observational studies. Her focus on diffuse midline gliomas with H3 K27M mutation and craniosynostosis-related syndromes aligns with the latest challenges in pediatric oncology. She bridges clinical care and biological research, aiming to personalize treatments and better understand tumor behavior. With a collaborative and multidisciplinary mindset, she contributes to both national registries and global efforts like the SIOPE DIPG Registry and SIOP EP II trials. Her mission is to enhance survival and quality of life for children through science-backed innovations and compassionate care 🧬❤️.
🏅 Awards and Honors
While no formal awards are explicitly listed, Dr. Lucia De Martino’s selection as Principal Investigator and Sub-Investigator on numerous national and international trials is itself a reflection of professional distinction and academic trust 🏆. Being entrusted with leadership roles in landmark studies such as the SIOP DIPG Registry, the International Ependymoma Program, and the Italian Pediatric Thrombosis Registry underlines her recognized expertise and contribution to pediatric oncology. Her participation in high-level training and international congresses — such as SIOP Europe and specialized workshops in pediatric oncology and neurosurgery — further confirms her position as a valued medical researcher. The trust placed in her by leading clinical figures (Dr. Quaglietta, Dr. Cinalli) and institutions like AORN Santobono-Pausilipon and Fondazione IRCCS demonstrates both peer recognition and leadership potential in the field of pediatric neuro-oncology 💫. These roles and appointments are a testament to her clinical excellence and research-driven vision 🧠💡.
🛠️ Skills
Dr. Lucia De Martino possesses a robust blend of clinical, research, and communication skills. Her clinical strengths include pediatric intensive care, neuro-oncology diagnostics, and oncological emergency management 👩⚕️. She is experienced with clinical trials management, including protocol development, data collection, and ethical oversight. She has strong command over digital tools like SPSS IBM, essential for research analysis. Her multilingualism in Italian, English, French, and German facilitates international collaboration 🌍. Additionally, Dr. De Martino is skilled in Good Clinical Practice (GCP) standards and Evidence-Based Medicine (EBM) applications. She thrives in multidisciplinary environments and is adept at translating complex clinical data into actionable treatment plans. Her participation in workshops on neurofibromatosis, pediatric pain, solid tumors, and rare congenital disorders further solidifies her practical expertise. Whether at bedside or in lab meetings, she brings clarity, compassion, and critical thinking to every clinical and academic interaction 🧑🔬💬📊.
Conclusion
Dr. Lucia De Martino demonstrates outstanding dedication to pediatric neuro-oncology, particularly in rare and aggressive brain tumors in children. Her consistent leadership in clinical trials, involvement in high-impact international collaborations, and contributions to translational research mark her as a strong and worthy candidate for the Best Researcher Award.
Publications to Noted
1. Primary Central Nervous System Tumors in Adolescents: A Population-Based Study on Epidemiology and Clinical Pathways in a Challenging Age Group
-
Authors: Lucia De Martino, Lucia Quaglietta, Peppino Mirabelli, et al.
-
Journal: Current Oncology
-
Year: 2025
-
Citations: Not available as of May 2025
🧬 2. Biobank for Craniosynostosis and Faciocraniosynostosis, Rare Pediatric Congenital Craniofacial Disorders: A Study Protocol
-
Authors: Lucia De Martino, Peppino Mirabelli, Lucia Quaglietta, Ursula Pia Ferrara, Stefania Picariello, Domenico Vincenzo De Gennaro, Marco Aiello, Giovanni Smaldone, Ferdinando Aliberti, Pietro Spennato, Daniele De Brasi, Eugenio Covelli, Giuseppe Cinalli
-
Journal: Child’s Nervous System
-
Year: 2024
-
Citations: Not available as of May 2025
🧠 3. Neuroimaging in Nonsyndromic Craniosynostosis: Key Concepts to Unlock Innovation
-
Authors: Lucia De Martino, et al.
-
Journal: Diagnostics
-
Year: 2024
-
Citations: Not available as of May 2025
🧪 4. Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules
-
Authors: Lucia De Martino, et al.
-
Journal: International Journal of Molecular Sciences
-
Year: 2024
-
Citations: Not available as of May 2025
🧬 5. Germline Mutations and New Copy Number Variants Among 40 Pediatric Cancer Patients Suspected for Genetic Predisposition
-
Authors: Lucia De Martino, et al.
-
Journal: Clinical Genetics
-
Year: 2019
-
Citations: Not available as of May 2025
🫁 6. Porcine vs Bovine Surfactant Therapy for Preterm Neonates with RDS: Systematic Review with Biological Plausibility and Pragmatic Meta-Analysis of Respiratory Outcomes
-
Authors: Lucia De Martino, et al.
-
Journal: Respiratory Research
-
Year: 2019
-
Citations: Not available as of May 2025
🧠 7. Symptomatic Malignant Spinal Cord Compression in Children: A Single-Center Experience
-
Authors: Lucia De Martino, Pietro Spennato, Salvatore Vetrella, et al.
-
Journal: Italian Journal of Pediatrics
-
Year: 2019
-
Citations: 25 (as per Mendeley)